Graphic Health Warnings on Cigarette Packaging Delayed Until 2023

Nov.16.2022
Graphic Health Warnings on Cigarette Packaging Delayed Until 2023
Graphic health warnings for cigarettes delayed until November 2023, per a Texas court order.

It won't be until early November 2023 that cigarette packaging and advertisements will feature graphic health warnings.


The Eastern District Court of Texas in the United States has issued an order to further delay the effective date of the Food and Drug Administration's (FDA) graphic cigarette health warning regulation from October 6, 2023, to November 6, 2023, for an additional 31 days.


According to the National Association of Tobacco Outlets (NATO), a court order issued on November 7 has extended the deadline for manufacturers and retailers to submit their preferred rotation plans for cigarette health warning labels to the FDA by 31 days.


Every tobacco manufacturer and retailer who makes their own cigarette advertisements is required to submit a plan to the FDA that outlines a schedule for rotating the use of 11 graphic cigarette health warnings in their ads. The association stated that the preferred submission deadline for the cigarette health warning rotation plan is now January 6, 2023.


According to NATO, the court is expected to make a ruling on the motion for summary judgment in the case within 31 days.


In March 2020, the FDA released a final rule about warnings that includes text and image combinations that describe some of the health risks associated with smoking. However, implementation has been repeatedly delayed after several tobacco companies requested a specific date be set.


The Eastern District Court of Texas has postponed the deadline for the final time on August 20, setting the new deadline for October 6, 2023.


These warnings must appear on the top 50% of the front and back of cigarette packaging, as well as on at least 20% of the top of cigarette advertisements. Additionally, as previously reported by Convenience Store News, these warnings must be randomly and evenly displayed and distributed on cigarette packaging, and rotated quarterly in cigarette advertisements.


There are 11 essential warnings that need to be addressed. They include:


Warning: Tobacco smoke can harm your children. Warning: Tobacco smoke can cause deadly lung diseases in non-smokers. Warning: Smoking can lead to head and neck cancer. Warning: Smoking can cause bladder cancer, leading to blood in urine. Warning: Smoking during pregnancy can hinder fetal growth. Warning: Smoking can block arteries, leading to heart disease and stroke. Warning: Smoking can cause chronic obstructive pulmonary disease, a potentially fatal lung disease. Warning: Smoking can decrease blood flow and cause erectile dysfunction. Warning: Smoking can decrease blood flow to the limbs, possibly requiring amputation. Warning: Smoking can cause type 2 diabetes, raising blood sugar. Warning: Smoking can cause cataracts, leading to blindness.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
At the GFN 2025, representatives from the world’s four largest tobacco companies emphasized the need for science-driven harm reduction policies. They urged regulators to move beyond outdated approaches and adopt consumer-focused, evidence-based frameworks to better serve public health goals.
Jun.26
KT&G Shifts HTP Production to Malaysia, 'lil Hybrid 3.0' Supply Normalizes
KT&G Shifts HTP Production to Malaysia, 'lil Hybrid 3.0' Supply Normalizes
South Korea's KT&G has moved its production of the "lil Hybrid 3.0" heated tobacco device from Vietnam to Malaysia, responding to Vietnam's impending ban on e-cigarettes and heated tobacco products. The relocation has resolved prior supply disruptions, with normal distribution resuming earlier this month. KT&G's "lil" series currently holds approximately 45.8% of South Korea's heated tobacco market, maintaining a lead over PMI.
May.09 by 2FIRSTS.ai
Philippine Tax Bureau Launches Digital Tracking System to Combat E-Cigarette Tax Evasion and Smuggling
Philippine Tax Bureau Launches Digital Tracking System to Combat E-Cigarette Tax Evasion and Smuggling
The Philippine Bureau of Internal Revenue is developing a digital tracking system for e-cigarettes using QR codes, allowing consumers to verify product authenticity via smartphones. This initiative aims to curb smuggling and tax evasion, with the agency's chief noting that illegal e-cigarettes have resulted in tax losses of billions of pesos ($17 million).
Jun.24 by 2FIRSTS.ai
U.S. Texas House Passes SB 2024: Proposal to Ban Chinese-Made E-Cigarettes and Curb Youth-Targeted Marketing
U.S. Texas House Passes SB 2024: Proposal to Ban Chinese-Made E-Cigarettes and Curb Youth-Targeted Marketing
Texas House passes bill SB 2024 expanding e-cigarette definition, banning products made in China, and limiting marketing strategies aimed at minors.
May.29 by 2FIRSTS.ai
Ireland Seizes Nearly 10 Million Illegal Cigarettes at Dublin Port, Worth €9 Million
Ireland Seizes Nearly 10 Million Illegal Cigarettes at Dublin Port, Worth €9 Million
Customs officers at Ireland’s Dublin Port have seized nearly 10 million illegal cigarettes, with an estimated value of €9 million. The brands involved include Marlboro Gold, Richmond Blue, and Marlboro Red. Authorities say the haul could have cost the state over €7 million in lost tax revenue.
May.16 by 2FIRSTS.ai
Ispire Reports FY2025 Q3 Revenue Down 12.7% to $26.2M; Secures Temporary Nicotine Production License in Malaysia
Ispire Reports FY2025 Q3 Revenue Down 12.7% to $26.2M; Secures Temporary Nicotine Production License in Malaysia
Ispire’s FY2025 Q3 revenue fell 12.7% to $26.2 million, with net loss widening to $10.9 million. The company is shifting manufacturing to Malaysia, aiming to cut costs by $8 million annually, and has obtained a temporary nicotine production license. It also filed a blockchain-based PMTA component with the FDA and launched the Sprout™ cannabis device with Raw Garden to grow its presence in emerging markets.
May.13 by 2FIRSTS.ai